Because of the existing inconsistencies in assessment of the individual impact of BCL2 and BAX expression level on AML prognosis, researchers have resorted to BAX/BCL2 ratio analysis.9,19 Namely, BAX and BCL2 regulate apoptotic process by binding to each other and thus forming heterodimers. The gene discussed is BCL2; the disease is acute myeloid leukemia.